Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program
Plasma collection began in two Brazilian hospitals for treatment of severe/critical patients. Donor's weight, days between disease onset and serial plasma collection are important predictors for neutralizing antibody titer.
